ScienceDex / Researcher record
Leber, Andrew
- Biotherapeutics, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2019 | $233,239 | 1 | #33,167 |
| 2021 | $943,417 | 2 | #10,032 |
| 2022 | $563,659 | 1 | #20,695 |
| 2023 | $919,727 | 2 | #11,365 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20191 record
- FY20212 records
- FY20221 record
- FY2023 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2019 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing Leber, Andrew as a PI. Multi-PI records show the full award amount for context.
- 5R44AI156952-03R44Contact PINovel Immunoregulatory Therapeutics for Systemic Lupus Erythematosus$563.7Kaward amount
- 1R43DK135158-01A1R43Contact PIImmunoregulatory Therapeutics for Ulcerative Colitis$356.1Kaward amount
Award organization
Organizations that administered FY2023 awards listing Leber, Andrew as a PI.
FY2023 award administered by Biotherapeutics, Inc. (VA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2019First NIH AwardBiotherapeutics, Inc.
- 2021$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2023$2M Cumulative Funding